NCT02136563View on ClinicalTrials.gov

Renal Prognosis in Chronic Kidney Disease Patients With Hyporesponsive Anemia to Erythropoiesis Stimulating Agents

CompletedOBSERVATIONAL

Enrollment

2,000

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions

Renal AnemiaChronic Kidney Disease

Trial Locations (1)

950-2181

Niigata University Graduate School of Medicine, Niigata

All Listed Sponsors

collaborator

Niigata University

UNKNOWN

lead

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

OTHER

NCT02136563 - Renal Prognosis in Chronic Kidney Disease Patients With Hyporesponsive Anemia to Erythropoiesis Stimulating Agents | Biotech Hunter | Biotech Hunter